INTS · Intensity Therapeutics Inc
United States · RS rating 9 · As of 2026-10-14
| Price | 3.42 USD |
|---|---|
| 1-day change | -3.7% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 23 / 12 / 13 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 14 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -15.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +89.6% |
| Market cap (USD) | $13.5M |